Objectives: To quantify life expectancy (LE), quality-adjusted life years (QALYs) and total
lifetime societal costs for a hypothetical cohort of Australians with multiple sclerosis (MS) …

Background Mortality studies in multiple sclerosis (MS) are valuable to identify changing
disease patterns and inform clinical management. This study examines mortality in a British …

This cost-of-illness analysis for the United Kingdom is part of a Europe-wide study on the
costs of multiple sclerosis (MS). The objective was to analyze the costs and quality of life …

Background: Multiple sclerosis (MS) has a major impact on health and is a substantial
burden on patients and society. We estimated the annual costs of MS in Australia from …

Aims: This paper evaluates the impact of multiple sclerosis (MS) in Ireland, and estimates
the associated direct, indirect, and intangible costs to society based on a large nationally …

Background: The measurement of health state utility values (HSUVs) for a representative
sample of Australian people with multiple sclerosis (MS) has not previously been performed …

Introduction: In order to estimate the value of interventions in multiple sclerosis (MS)–where
lifetime costs and outcomes cannot be observed–outcome data have to be combined with …

Introduction Multiple sclerosis (MS) has significant financial consequences for healthcare
systems, individual patients and households, and the wider society. This study examines the …

We performed a cross-sectional, bottom-up observational study of resource consumption
and quality of life of patients with multiple sclerosis (MS) in the United Kingdom. Three …

Background: Transition probabilities are the engine within many health economics decision
models. However, the probabilities of progression of disability due to multiple sclerosis (MS) …